儿科介入性心臟病学市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按设备类型、程序、地区、竞争预测和机会细分，2018-2028 年

2022年，全球儿科介入性心臟病学市场估值为24.1亿美元，预计在预测期内将呈现显着增长，预计到2028年复合年增长率（CAGR）为6.72%。该市场代表着一个充满活力的市场并在更广泛的医疗保健领域内迅速推进该行业。其主要重点是采用微创技术和程序诊断和治疗儿科患者的各种心血管疾病。以下是与全球儿科介入性心臟病学市场相关的主要亮点的简要总结。

主要市场驱动因素

先天性心臟病 (CHD) 的发生率不断上升

市场概况
预测期	2024-2028
2022 年市场规模	24.1亿美元
2028 年市场规模	35.7亿美元
2023-2028 年复合年增长率	6.72%
成长最快的细分市场	封闭装置
最大的市场	北美洲

先天性心臟病 (CHD) 是影响全世界新生儿和婴儿的重大健康问题。这些复杂的心臟疾病通常需要专门的医疗干预措施进行诊断和治疗。近年来，冠心病的发生率显着增加，推动了全球儿科介入性心臟病学市场的成长。 CHD 是指出生时出现的一组结构性和功能性心臟异常。这些情况的范围从轻微到严重，可能会影响心室、瓣膜、血管或电气系统。虽然有些病例是早期诊断出来的，但其他病例可能只有在童年后期才变得明显。冠心病的严重性和复杂性需要专门的诊断和治疗方法。超音波心动图、胎儿超音波和基因检测等医学影像技术的进步使得在怀孕期间和出生后更容易检测先天性心臟病。早期诊断可以及时介入并改善结果。 CHD 的常规产前筛检已变得更加普遍。这使得医疗保健专业人员能够在出生前识别潜在的心臟缺陷，从而能够及早规划治疗或手术。手术技术和术后护理的改进显着提高了先天性心臟病婴儿的存活率。随着越来越多的患有先心病的儿童存活到成年，对持续心臟护理和介入的需求也在增长。有些环境和遗传因素与先心病的发生有关。对这些风险因素的更好了解提高了人们对预防和治疗的认识和研究。随着被诊断患有先心病的儿童数量持续增长，对专业心臟护理的需求也越来越高。儿科心臟科医生和介入性心臟病专家对于使用微创手术诊断和治疗这些疾病至关重要。儿科介入性心臟病学领域不断发展，以满足先心病患者的多样化需求。导管插入术、装置植入和其他微创手术的进步使治疗更安全、更有效。儿科介入性心臟病学市场的成长并不限于已开发国家。新兴经济体的冠心病病例也有所增加，导致对医疗基础设施和专门心臟护理服务的投资增加。冠心病病例激增引发了广泛的研究和临床试验，从而产生了创新的解决方案和实证治疗。这项研究透过扩大治疗选择和改善结果使患者受益。

微创技术

近年来，儿科介入性心臟病学领域取得了显着成长，这在很大程度上得益于微创技术的采用。这些创新程序改变了儿童心臟病的诊断和治疗方式。儿科心臟病学的微创技术涉及使用导管、专用设备和影像技术来诊断和治疗各种心臟疾病，而无需进行心臟直视手术。这些技术为医疗保健提供者和年轻患者提供了多种优势。微创手术通常涉及较小的切口或根本没有切口。这显着降低了併发症的风险，例如感染和过度出血，这些併发症在传统的心臟直视手术中更为常见。微创方法通常可以缩短住院时间并加快復原时间。孩子可以更快恢復正常活动，最大限度地减少对日常生活的干扰。较小的切口意味着较少的疼痛和疤痕。这对于儿科患者尤其重要，因为他们通常对疼痛更敏感，并且可能会因明显的手术疤痕而遭受心理困扰。微创手术可以降低术后感染的风险，这对儿科患者的整体健康至关重要。先进的影像技术，例如透视和超音波心动图，在微创手术过程中提供即时指导。这样可以精确放置导管和装置，从而提高治疗的整体效果。由于在安全性、恢復和美容效果方面的优势，家长和照护者越来越多地为孩子寻求传统心臟直视手术的微创替代方案。医疗技术的不断进步带来了专为儿科患者设计的更复杂的导管、影像系统和设备。这些创新使心臟科医生能够以更高的精度执行更广泛的手术。随着临床医生在微创技术方面获得更多经验，他们可以解决更广泛的心臟疾病，包括先前仅透过心臟直视手术治疗的复杂先天性心臟病。

多学科合作

近年来，全球儿科介入性心臟病学市场经历了显着增长，很大程度上是由于儿童心臟病病例日益复杂。这种成长的关键驱动力是对医疗保健专业人员之间多学科合作的重视。儿科介入心臟病学的多学科合作涉及来自不同专业的医疗保健专业人员共同诊断和治疗儿童复杂的心臟病。这些团队通常由诊断和管理儿童心臟病的专家组成。它们在患者的整体评估和管理中发挥关键作用。擅长微创手术和导管介入。他们进行广泛的诊断和治疗程序来解决心臟问题。使用透视、超音波心动图和 MRI 等技术提供重要的影像支援。他们的即时成像指导对于准确的诊断和介入至关重要。儘管微创技术减少了心臟直视手术的需要，但心臟外科医师对于需要手术介入的复杂病例仍然至关重要。多学科团队可以对儿童的心臟病进行全面评估，从而获得更准确的诊断和量身定制的治疗计划。这种方法确保为每位患者选择正确的介入措施。合作使医疗保健专业人员能够解决儿科患者更广泛的心臟病问题。复杂的先天性心臟病曾经主要透过心臟直视手术进行治疗，现在可以透过集体专业知识使用微创技术进行治疗。多学科团队培育创新和研究文化。来自不同领域的专家的综合知识和经验推动了新手术、设备和治疗方法的发展。透过确保手术由各自领域的专家执行，协作可以最大限度地减少併发症的风险。这不仅提高了患者的安全性，也降低了与併发症相关的医疗费用。

新兴经济体

近年来，全球儿科介入性心臟病学市场出现了显着成长，而这一扩张的关键驱动力之一是新兴经济体的贡献不断增加。这些地区的特点是医疗基础设施不断完善、医疗服务可近性不断提高、医疗保健支出不断增长，在推动市场发展方面发挥着至关重要的作用。新兴经济体正在大力投资医疗基础建设，包括建立专门的儿科心臟护理中心。这些设施配备了先进的技术和熟练的劳动力，使他们能够为儿童提供高品质的心臟护理。随着新兴经济体医疗保健可近性的改善，更多的家庭可以获得医疗服务。这种更广泛的获取机会可以更早发现和诊断儿科心臟病，从而对介入性心臟病学服务产生更大的需求。新兴经济体的经济成长导致政府和个人的医疗保健支出增加。因此，先进的医疗治疗（包括儿科介入性心臟病学手术）获得了更多的财务支持。一些新兴经济体正成为医疗旅游目的地，吸引来自本国和国外的病患。提供专业介入性心臟病学服务的儿科心臟护理中心可以从这一趋势中受益，推动市场成长。新兴经济体正在投资当地医疗保健专业人员的培训和发展，包括儿科心臟病专家和介入性心臟病专家。这不仅减少了对外国专业知识的依赖，而且增强了当地解决儿科心臟问题的能力。新兴经济体医疗保健基础设施的成长和医疗保健支出的增加直接促进了儿科介入性心臟病学服务的扩展。随着这些经济体投资最新的医疗技术和研究，儿科心臟护理领域的创新不断涌现，使全球市场受益。新兴经济体和较发达地区医疗机构之间的合作促进知识交流和研究机会，最终提高全球护理品质。新兴经济体的竞争和成本压力可能会导致医疗保健服务的提供更具成本效益，从而使专门的儿科心臟护理变得更加负担得起和容易获得。

主要市场挑战

获得特殊护理的机会有限

最紧迫的挑战之一是获得专门的儿科心臟护理的机会有限，特别是在低收入和农村地区。这些地区的许多儿童无法获得必要的诊断工具和熟练的医疗保健提供者来进行及时介入。

缺乏训练有素的专业人员

小儿介入心臟病学需要高技能和专业的劳动力。缺乏训练有素的儿科心臟病专家、介入性心臟病专家和相关医疗保健专业人员，特别是在发展中国家。这种短缺可能会导致诊断和治疗的延迟。

复杂的案例和专业知识

一些儿科心臟病病例异常复杂，需要高水准的专业知识和经验。有效管理这些病例可能具有挑战性，并非所有医疗机构都拥有必要的资源或专业知识。

设备与技术

跟上最新的医疗设备和技术对于儿科介入性心臟病学至关重要。许多医疗机构，尤其是在资源有限的环境中，都在努力取得和维护最先进的设备。

主要市场趋势

经导管瓣膜治疗

经导管瓣膜置换和修復手术在儿科心臟科中越来越受到重视。这些技术允许使用微创方法更换或修復心臟瓣膜，从而减少心臟直视手术的需求及其相关风险。

胎儿心臟干预

胎儿心臟介入领域正在迅速发展。在子宫内进行的手术变得越来越复杂，甚至可以在出生前治疗先天性心臟病。这种趋势有可能显着改善结果。

3D 列印和个人化植入物

3D 列印技术越来越多地用于为儿科心臟病患者製造个人化植入物和设备。这些客製化的解决方案提高了介入措施的准确性和有效性，从而带来更好的结果。

微创机器人手术

在微创手术中使用机器人技术在儿科心臟病学中越来越受到关注。机器人辅助手术提供更高的精确度和控制，减少手术的侵入性。

细分市场洞察

设备类型洞察

根据设备类型的类别，支架细分市场预计在预测期内将会成长。心臟病患病率上升等因素，以及公共和私人组织采取的倡议，预计将刺激这一领域的成长。市面上有多种用于儿科介入性心臟病手术的支架类型。其中包括裸支架、药物洗脱支架和生物可吸收支架等。值得注意的是，与裸支架和药物洗脱支架相比，生物可吸收支架代表了更先进的选择。生物可吸收支架由金属或聚合物材料组成，可逐渐溶解或吸收到体内。它们具有不留下永久性金属假体的优点，这有助于防止支架最终溶解时出现血栓形成和再狭窄等併发症。

程式见解

基于导管的瓣膜植入术因其众多优势和不断增加的采用率而有望主导全球儿科介入性心臟病学市场。与传统的心臟直视手术不同，基于导管的手术是微创的，可以降低儿科患者的风险、缩短恢復时间并减少疤痕。这些手术在治疗儿童各种先天性和后天性心臟病（包括瓣膜缺陷）方面显示出显着的疗效。此外，基于导管的技术的不断进步，以及专门的儿科设备和支架的开发，正在提高其精度和有效性。随着医疗保健提供者和家长寻求治疗儿科心臟病的侵入性较小的选择，基于导管的瓣膜植入术正在成为首选，从而推动其在全球市场的主导地位。

区域洞察

在先天性心臟病发病率增加和该领域技术进步等多种因素的推动下，儿科介入性心臟病学领域在北美正在经历强劲增长。值得注意的是，心臟病仍然是美国普遍存在的健康问题，CDC 截至 2022 年 10 月的统计数据表明，很大一部分儿童面临健康挑战。例如，据报道，2021 年，美国约 1.3% 的 0-4 岁儿童健康状况一般或较差，约 3.3% 的 5-11 岁儿童在过去一年缺课 11 天或以上因生病或受伤。此外，同一来源的资料显示，美国约20.3%的6至11岁儿童患有肥胖症，这是各种心血管疾病的主要危险因子。因此，儿科心臟病的负担预计会增加，从而推动该国市场的成长。

市场成长的另一个重要动力是主要产业参与者的积极参与。例如，2021 年3 月，美国FDA 批准了Harmony 经导管肺动脉瓣(TPV)，这是世界上第一个非手术心臟瓣膜，旨在治疗具有天然或手术修復右心室流出道(RVOT) 的儿童和成人患者。这种创新设备专为患有严重肺动脉瓣逆流的患者量身定制，旨在透过增强肺部血流来减少其一生所需的心臟直视手术频率。这些开创性的倡议有助于扩大儿科介入性心臟病学市场。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按地区
  • 按公司划分 (2022)
• 产品市场地图
  • 依设备类型
  • 按程式
  • 按地区

第 6 章：北美儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙

第 8 章：亚太地区儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国

第 9 章：南美洲儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲儿科介入性心臟病学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依设备类型（封堵设备、经导管心臟瓣膜、粥状斑块切除设备、导管、球囊、支架等）
  • 依手术方式（导管瓣膜植入术、先天性心臟缺陷矫正术、血管成形术、冠状动脉血栓切除术等）
  • 按国家/地区
• MEA：国家分析
  • 南非小儿介入性心臟病学
  • 沙乌地阿拉伯小儿介入心臟病学
  • 阿联酋小儿介入心臟病学
  • 科威特小儿介入性心臟病学

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第14章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • Abbott Laboratories Inc
  • Biotronik Inc
  • Boston Scientific Corporation
  • Canon Medical Systems Corp
  • Cardinal Health Inc
  • Cordis Corp
  • Edwards Lifesciences LLC
  • GE Healthcare Inc
  • Medtronic Inc
  • Siemens Healthineers AG

第 15 章：策略建议

第 16 章：关于我们与免责声明

In 2022, the Global Pediatric Interventional Cardiology Market was valued at USD 2.41 billion, and it is expected to demonstrate remarkable growth in the forecasted period, with a projected Compound Annual Growth Rate (CAGR) of 6.72% through 2028. This market represents a dynamic and swiftly advancing sector within the broader domain of healthcare. Its primary focus lies in the diagnosis and treatment of diverse cardiovascular conditions in pediatric patients, employing minimally invasive techniques and procedures. Here is a succinct summary of the key highlights related to the Global Pediatric Interventional Cardiology Market.

Key Market Drivers

Rising Incidence of Congenital Heart Diseases (CHD)

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 2.41 Billion
Market Size 2028	USD 3.57 Billion
CAGR 2023-2028	6.72%
Fastest Growing Segment	Closure Devices
Largest Market	North America

Congenital Heart Diseases (CHD) represent a significant health concern affecting newborns and infants worldwide. These complex heart conditions often require specialized medical interventions for diagnosis and treatment. In recent years, there has been a notable increase in the incidence of CHD, which is driving the growth of the Global Pediatric Interventional Cardiology Market. CHD refers to a group of structural and functional heart abnormalities present at birth. These conditions can range from mild to severe and may affect the heart's chambers, valves, blood vessels, or the electrical system. While some cases are diagnosed early, others may only become evident later in childhood. The severity and complexity of CHD require a specialized approach to diagnosis and treatment. Advances in medical imaging technologies, such as echocardiography, fetal ultrasound, and genetic testing, have made it easier to detect CHD during pregnancy and after birth. Early diagnosis leads to prompt intervention and improved outcomes. Routine prenatal screening for CHD has become more widespread. This has allowed healthcare professionals to identify potential heart defects before birth, enabling early planning for treatment or surgery. Improved surgical techniques and postoperative care have significantly increased the survival rates of infants born with CHD. As more children with CHD survive into adulthood, the demand for ongoing cardiac care and interventions grows. Some environmental and genetic factors have been linked to the development of CHD. A better understanding of these risk factors has led to increased awareness and research into prevention and treatment. As the number of children diagnosed with CHD continues to grow, there is a higher demand for specialized cardiac care. Pediatric cardiologists and interventional cardiologists are essential in diagnosing and treating these conditions using minimally invasive procedures. The pediatric interventional cardiology field is continually evolving to address the diverse needs of CHD patients. Advancements in catheterization, device implantation, and other minimally invasive procedures are making treatment safer and more effective. The growth of the pediatric interventional cardiology market is not limited to developed countries. Emerging economies are also witnessing an increase in CHD cases, leading to greater investment in healthcare infrastructure and specialized cardiac care services. The surge in CHD cases has prompted extensive research and clinical trials, resulting in innovative solutions and evidence-based treatments. This research benefits patients by expanding treatment options and improving outcomes.

Minimally Invasive Techniques

In recent years, the field of pediatric interventional cardiology has witnessed significant growth, driven in large part by the adoption of minimally invasive techniques. These innovative procedures have transformed the way cardiac conditions in children are diagnosed and treated. Minimally invasive techniques in pediatric cardiology involve the use of catheters, specialized equipment, and imaging technology to diagnose and treat a wide range of cardiac conditions without the need for open-heart surgery. These techniques offer several advantages, both for healthcare providers and young patients. Minimally invasive procedures generally involve smaller incisions or no incisions at all. This significantly reduces the risk of complications, such as infection and excessive bleeding, which are more common in traditional open-heart surgeries. The minimally invasive approach typically results in shorter hospital stays and quicker recovery times. Children can return to their normal activities sooner, minimizing disruptions to their daily lives. Smaller incisions mean less pain and scarring. This aspect is particularly important for pediatric patients, as they are often more sensitive to pain and may experience psychological distress from visible surgical scars. Minimally invasive procedures are associated with a lower risk of postoperative infections, which is crucial for the overall well-being of pediatric patients. Advanced imaging technologies, such as fluoroscopy and echocardiography, provide real-time guidance during minimally invasive procedures. This allows for precise placement of catheters and devices, enhancing the overall effectiveness of the treatment. Parents and caregivers are increasingly seeking minimally invasive alternatives to traditional open-heart surgeries for their children due to the perceived benefits in terms of safety, recovery, and cosmetic outcomes. Continuous advancements in medical technology have resulted in more sophisticated catheters, imaging systems, and devices designed specifically for pediatric patients. These innovations enable cardiologists to perform a broader range of procedures with greater precision. As clinicians gain more experience with minimally invasive techniques, they can address a wider range of cardiac conditions, including complex congenital heart diseases that were previously managed solely through open-heart surgery.

Multidisciplinary Collaboration

The Global Pediatric Interventional Cardiology Market has experienced significant growth in recent years, largely due to the increasing complexity of cardiac cases in children. A critical driver of this growth is the emphasis on multidisciplinary collaboration among healthcare professionals. Multidisciplinary collaboration in pediatric interventional cardiology involves healthcare professionals from various specialties working together to diagnose and treat complex heart conditions in children. These teams typically consist of- experts in diagnosing and managing heart conditions in children. They play a pivotal role in the overall assessment and management of the patient. Skilled in minimally invasive procedures and catheter-based interventions. They perform a wide range of diagnostic and therapeutic procedures to address cardiac issues. Provide crucial imaging support using techniques such as fluoroscopy, echocardiography, and MRI. Their real-time imaging guidance is essential for accurate diagnosis and intervention. Although minimally invasive techniques have reduced the need for open-heart surgeries, cardiac surgeons are still vital for complex cases that require surgical intervention. Multidisciplinary teams can provide a comprehensive assessment of a child's heart condition, resulting in more accurate diagnoses and tailored treatment plans. This approach ensures that the right interventions are chosen for each patient. Collaboration enables healthcare professionals to address a broader spectrum of cardiac conditions in pediatric patients. Complex congenital heart diseases, once managed primarily through open-heart surgery, can now be treated using minimally invasive techniques thanks to collective expertise. Multidisciplinary teams foster a culture of innovation and research. The combined knowledge and experience of specialists from different fields drive the development of new procedures, devices, and treatment approaches. Collaboration minimizes the risk of complications by ensuring that procedures are performed by experts in their respective fields. This not only improves patient safety but also reduces healthcare costs associated with complications.

Emerging Economies

The Global Pediatric Interventional Cardiology Market has witnessed remarkable growth in recent years, and one of the key drivers of this expansion is the increasing contribution of emerging economies. These regions, characterized by rising healthcare infrastructure, improved access to medical services, and growing healthcare spending, are playing a crucial role in propelling the market's development. Emerging economies are investing significantly in healthcare infrastructure development, including the establishment of specialized pediatric cardiac care centers. These facilities are equipped with advanced technology and a skilled workforce, enabling them to provide high-quality cardiac care to children. As healthcare accessibility improves in emerging economies, more families have access to medical services. This heightened access leads to earlier detection and diagnosis of pediatric heart conditions, creating a greater demand for interventional cardiology services. Economic growth in emerging economies has resulted in increased healthcare spending by governments and individuals alike. As a result, there is greater financial support for advanced medical treatments, including pediatric interventional cardiology procedures. Some emerging economies are becoming destinations for medical tourism, attracting patients from both within their own countries and from abroad. Pediatric cardiac care centers that offer specialized interventional cardiology services can benefit from this trend, driving market growth. Emerging economies are investing in the training and development of local healthcare professionals, including pediatric cardiologists and interventional cardiologists. This not only reduces dependence on foreign expertise but also enhances the capacity to address pediatric cardiac issues locally. The growth of healthcare infrastructure and increased healthcare spending in emerging economies directly contributes to the expansion of pediatric interventional cardiology services. As these economies invest in the latest medical technology and research, innovations in pediatric cardiac care emerge, benefiting the global market. Collaborations between healthcare institutions in emerging economies and those in more developed regions foster knowledge exchange and research opportunities, ultimately enhancing the quality of care worldwide. Competition and cost pressures in emerging economies can lead to more cost-effective delivery of healthcare services, making specialized pediatric cardiac care more affordable and accessible.

Key Market Challenges

Limited Access to Specialized Care

One of the most pressing challenges is limited access to specialized pediatric cardiac care, particularly in low-income and rural areas. Many children in these regions do not have access to the necessary diagnostic tools and skilled healthcare providers for timely interventions.

Shortage of Trained Professionals

Pediatric interventional cardiology requires a highly skilled and specialized workforce. There is a shortage of trained pediatric cardiologists, interventional cardiologists, and allied healthcare professionals, especially in developing countries. This shortage can result in delayed diagnosis and treatment.

Complex Cases and Expertise

Some pediatric cardiac cases are exceptionally complex, requiring a high level of expertise and experience. Managing these cases effectively can be challenging, and not all healthcare facilities have the necessary resources or expertise.

Equipment and Technology

Keeping up with the latest medical equipment and technology is essential in pediatric interventional cardiology. Many healthcare facilities, especially in resource-constrained settings, struggle to acquire and maintain state-of-the-art equipment.

Key Market Trends

Transcatheter Valve Therapies

Transcatheter valve replacement and repair procedures are gaining prominence in pediatric cardiology. These techniques allow for the replacement or repair of cardiac valves using minimally invasive approaches, reducing the need for open-heart surgery and its associated risks.

Fetal Cardiac Interventions

The field of fetal cardiac interventions is rapidly advancing. Procedures performed in utero are becoming more sophisticated, enabling the treatment of congenital heart defects even before birth. This trend has the potential to improve outcomes significantly.

3D Printing and Personalized Implants

3D printing technology is being increasingly used to create personalized implants and devices for pediatric cardiac patients. These custom-made solutions improve the precision and effectiveness of interventions, leading to better outcomes.

Minimally Invasive Robotic Surgery

The use of robotics in minimally invasive procedures is gaining traction in pediatric cardiology. Robotic-assisted surgeries offer greater precision and control, reducing the invasiveness of procedures.

Segmental Insights

Device Type Insights

Based on the category of Device Type, the Stents segment is expected to rise during the forecast period. Factors such as the rising prevalence of heart diseases, along with initiatives undertaken by both public and private organizations, are anticipated to stimulate the growth of this segment. There is a variety of stent types available in the market for pediatric interventional cardiology procedures. These encompass bare stents, drug-eluting stents, and bio-absorbable stents, among others. Notably, bio-absorbable stents represent a more advanced option compared to both bare stents and drug-eluting stents. Bio-absorbable stents are composed of either metal or polymer materials that gradually dissolve or get absorbed into the body. They offer the advantage of not leaving permanent metallic prostheses behind, which helps in preventing complications such as thrombosis and restenosis as the stent eventually dissolves.

According to a research study published by SpringerOpen in November 2021, infants with congenital heart disease typically experience early decompensation. Specifically, heart failure occurs in approximately 20% of these infants within the first week of life, 18% between the first and fourth weeks, and another 20% between one and twelve months of age. Consequently, the substantial burden of congenital heart disease in infants is expected to drive the increased adoption of stents, thereby serving as a major catalyst for segment growth.

Furthermore, several initiatives and developments spearheaded by prominent organizations are poised to further bolster the growth of this segment. For instance, in July 2021, the American College of Cardiology (ACC) unveiled a partnership with Armus Corporation to introduce Global Quality Solutions, aimed at elevating the standard of cardiac care on a global scale. This initiative will initially roll out in South Africa, Brazil, and Saudi Arabia, with plans to expand its reach to additional nations and regions. Additionally, the growing pediatric population worldwide constitutes a significant factor that is poised to drive the adoption of stents in pediatric cardiology procedures, ultimately fueling the expansion of this segment.

Procedure Insights

Catheter-based valve implantation is poised to dominate the Global Pediatric Interventional Cardiology Market due to its numerous advantages and increasing adoption. Unlike traditional open-heart surgery, catheter-based procedures are minimally invasive, offering pediatric patients reduced risks, shorter recovery times, and less scarring. These procedures have shown remarkable efficacy in treating various congenital and acquired heart conditions in children, including valve defects. Furthermore, the continuous technological advancements in catheter-based techniques, along with the development of specialized pediatric devices and stents, are enhancing their precision and effectiveness. As healthcare providers and parents seek less invasive options for treating pediatric heart conditions, catheter-based valve implantation is emerging as a preferred choice, thereby driving its dominance in the global market.

Regional Insights

The pediatric interventional cardiology sector is experiencing robust growth in North America, driven by several factors including the increasing incidence of congenital heart diseases and technological advancements in the field. Notably, heart disease remains a prevalent health concern in the United States, with statistics from the CDC as of October 2022 indicating that a significant portion of children face health challenges. For instance, around 1.3% of children aged 0-4 in the United States were reported to be in fair or poor health conditions in 2021, and approximately 3.3% of children aged 5-11 missed 11 or more days of school within the past year due to illness or injury. Furthermore, the data from the same source reveals that about 20.3% of children aged 6 to 11 in the United States are dealing with obesity, a major risk factor for various cardiovascular diseases. Consequently, the burden of pediatric cardiac ailments is expected to rise, driving market growth in the country.

Another significant driver of market growth is the proactive involvement of key industry players. For example, in March 2021, the United States FDA granted approval for the Harmony Transcatheter Pulmonary Valve (TPV) as the world's first nonsurgical heart valve designed to treat both pediatric and adult patients with native or surgically repaired right ventricular outflow tract (RVOT). This innovative device is tailored for patients experiencing severe pulmonary valve regurgitation and aims to reduce the frequency of open-heart surgeries required throughout their lifetime by enhancing blood flow to the lungs. Such groundbreaking initiatives are contributing to the expansion of the pediatric interventional cardiology market.

Key Market Players

• Abbott Laboratories Inc

• Biotronik Inc

• Boston Scientific Corporation

• Canon Medical Systems Corp

• Cardinal Health Inc

• Cordis Corp

• Edwards Lifesciences LLC

• GE Healthcare Inc

• Medtronic Inc

• Siemens Healthineers AG

Report Scope:

In this report, the Global Pediatric Interventional Cardiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pediatric Interventional Cardiology Market, By Device Type:

• Closure Devices
• Transcatheter Heart Valves
• Atherectomy Devices
• Catheters
• Balloons
• Stents
• Others

Pediatric Interventional Cardiology Market, By Procedure:

• Catheter-Based Valve Implantation
• Congenital Heart Defect Correction
• Angioplasty
• Coronary Thrombectomy
• Others

Pediatric Interventional Cardiology Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Pediatric Interventional Cardiology Market.

Available Customizations:

• Global Pediatric Interventional Cardiology market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pediatric Interventional Cardiology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 5.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Market Map
  • 5.3.1. By Device Type
  • 5.3.2. By Procedure
  • 5.3.3. By Region

6. North America Pediatric Interventional Cardiology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 6.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pediatric Interventional Cardiology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Procedure
  • 6.3.2. Canada Pediatric Interventional Cardiology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Procedure
  • 6.3.3. Mexico Pediatric Interventional Cardiology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Procedure

7. Europe Pediatric Interventional Cardiology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 7.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pediatric Interventional Cardiology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Procedure
  • 7.3.2. United Kingdom Pediatric Interventional Cardiology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Procedure
  • 7.3.3. France Pediatric Interventional Cardiology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Procedure
  • 7.3.4. Italy Pediatric Interventional Cardiology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Procedure
  • 7.3.5. Spain Pediatric Interventional Cardiology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Procedure

8. Asia-Pacific Pediatric Interventional Cardiology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 8.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Pediatric Interventional Cardiology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Procedure
  • 8.3.2. Japan Pediatric Interventional Cardiology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Procedure
  • 8.3.3. India Pediatric Interventional Cardiology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Procedure
  • 8.3.4. Australia Pediatric Interventional Cardiology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Procedure
  • 8.3.5. South Korea Pediatric Interventional Cardiology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Procedure

9. South America Pediatric Interventional Cardiology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 9.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Pediatric Interventional Cardiology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Procedure
  • 9.3.2. Argentina Pediatric Interventional Cardiology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Procedure
  • 9.3.3. Colombia Pediatric Interventional Cardiology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Procedure

10. Middle East and Africa Pediatric Interventional Cardiology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type (Closure Devices, Transcatheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Others)
  • 10.2.2. By Procedure (Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Pediatric Interventional Cardiology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Procedure
  • 10.3.2. Saudi Arabia Pediatric Interventional Cardiology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Procedure
  • 10.3.3. UAE Pediatric Interventional Cardiology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Procedure
  • 10.3.4. Kuwait Pediatric Interventional Cardiology Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Device Type
      • 10.3.4.2.2. By Procedure

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Business Overview
• 14.2. Product Offerings
• 14.3. Recent Developments
• 14.4. Financials (As Reported)
• 14.5. Key Personnel
• 14.6. SWOT Analysis
  • 14.6.1. Abbott Laboratories Inc
  • 14.6.2. Biotronik Inc
  • 14.6.3. Boston Scientific Corporation
  • 14.6.4. Canon Medical Systems Corp
  • 14.6.5. Cardinal Health Inc
  • 14.6.6. Cordis Corp
  • 14.6.7. Edwards Lifesciences LLC
  • 14.6.8. GE Healthcare Inc
  • 14.6.9. Medtronic Inc
  • 14.6.10. Siemens Healthineers AG

15. Strategic Recommendations

16. About Us & Disclaimer